Video

Dr. Rao on Improving Methods of Early Detection of Ovarian Cancer

Author(s):

Jianyu Rao, MD, professor and chief of Cytopathology, University of California, Los Angeles, discusses improving methods of early detection of ovarian cancer.

Jianyu Rao, MD, professor and chief of Cytopathology, University of California, Los Angeles, discusses improving methods of early detection of ovarian cancer.

In discussions regarding the relationship between genes and histology, physicians and pathologists are trying to determine if there is a way to improve early detection approaches, says Rao. One thing that Rao believes that there must be a better understanding of not only the BRCA genes, but other genes that may be involved in more sporadic cancers. Then, physicians can develop and refine non-invasive approaches like liquid biopsies.

The Hopkins group developed an algorithm to simultaneously analyze proteins and genes together with the hope of improving early detection. However, Rao notes that physicians and pathologists are still waiting to see if it will be clinically useful or not.

Related Videos
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD
Jonathan Wesley Riess, MD, MS, an associate professor at the University of California (UC) Davis
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Laura A. Huppert, MD
Polly Niravath, MD